COVALENT GROUP GETS $3.4 MILLION IN NEW BUSINESS AWARDS.
Covalent Group, Inc. (NASDAQ:CVGR), Wayne, Pa., has announced the
awarding of contracts with five different pharmaceutical companies whose
corporate headquarters are located in the United States . . .
NORAC SIGNS LETTER OF INTENT FOR AMALGAMATION WITH VIREXX.(Norac
Industries Inc.)(Brief Article)
Norac Industries, Inc., (TSX-V:NRC.T), Edmonton, Alberta, Canada,
has announced that a Letter of Intent has been entered into between
Norac and ViRexx Research Inc. pursuant to which Norac and . . .
AKZO NOBEL REJECTS CRITICISM OF 2002 FINANCIAL STATEMENTS.(Brief
Article)
Akzo Nobel, Arnhem, the Netherlands, has rejected the criticism
expressed by "Stichting Onderzoek Bedrijfs Informatie" (SOBI)
of the reporting of pension liabilities in the 2002 . . .
BIOGEN EXPECTS QUARTERLY EARNINGS TO BE UNEVEN DURING 2003.(Brief
Article)
Biogen, Inc. (NASDAQ:BGEN), Cambridge, Mass., has reconfirmed
operating earnings per share guidance for full year 2003 of $1.72 to
$1.85. Biogen reiterated previous guidance that it expects . . .
GENEREX REPORTS A NET LOSS OF $2.6 MILLION FOR THIRD QTR.(Generex
Biotechnology Corp.)(Brief Article)
Generex Biotechnology Corporation (NASDAQ:GNBT), Toronto, a leader
in the area of buccal drug delivery, has announced financial results for
its third fiscal quarter ended April 30, 2003.
The . . .
DISCOVERY REPORTS FIRST QTR '03 NET LOSS OF $4.5
MILLION.(Discovery Laboratories, Inc.)
Discovery Laboratories, Inc. (Nasdaq: DSCO), Doylestown, Pa. a
late-stage specialty biopharmaceutical company developing its
proprietary surfactant technology as Surfactant Replacement . . .
HALSEY REPORTS REVENUES DECREASED 19% FOR FIRST QTR 2003.(Halsey
Pharmaceuticals)(Brief Article)
Halsey Pharmaceuticals (OTCBB-HDGC), Rockford, Ill., has announced
that revenues for the quarter ended March 31, 2003 decreased 19% to
$1,526,000 as compared to revenues of $1,881,000 for quarter . . .
DRAXIS REPORTS NET INCOME OF $806.000 FOR FIRST QTR
'03.(DRAXIS Health Inc.)
DRAXIS Health Inc. (Nasdaq:DRAX)(TSX:DAX), Mississauga, Ontario,
has reported financial results for the first quarter of 2003 ended March
31, 2003. All amounts are expressed in US dollars. Revenues . . .
CYANOTECH REPORTS NET SALES UP 18% FOR 4TH QTR 2003.
Cyanotech Corporation (Nasdaq:CYAN), Kailua-Kona, Hawaii, a world
leader in producing high-value natural products from microalgae, has
announced financial results for the fourth quarter and fiscal . . .
IMMUCELL REPORTS PROFIT FOR FIRST QTR OF 2003.
ImmuCell Corporation (NASDAQ: ICCC), Portland, Maine, has announced
the results of its operations for the three months ended March 31, 2003.
During the three months ended March 31, 2003, total . . .
HYCOR REPORTS FIRST QTR NET INCOME OF $331.000.(Hycor Biomedical
Inc. )
Hycor Biomedical Inc. (Nasdaq:HYBD), Garden Grove, Calif., has
reported net income of $331,000, or $0.04 per share on sales of
$4,878,000 for the first quarter ended March 31, 2003.
The results . . .
COLLAGENEX REPORTS FIRST QTR TOTAL REVENUES INCREASE
13%.(CollaGenex Pharmaceuticals)
CollaGenex Pharmaceuticals, Inc. (Nasdaq: CGPI), Newton. Pa., has
reported financial results for the first quarter ended March 31, 2003.
Total revenues increased 13% to $12.2 million compared to . . .
ZOLL REPORTS RECORD 2ND QTR REVENUE INCREASE OF 34%.(ZOLL Medical
Corp.)
ZOLL Medical Corporation (Nasdaq:ZOLL), Burlington, Mass. a
manufacturer of non-invasive cardiac resuscitation devices which provide
pacing and defibrillation, has announced record second quarter . . .
MEDAREX REPORTS NET LOSS OF $35 MILLION FOR 4TH QTR 2002.
Medarex, Inc. (Nasdaq: MEDX), Princeton, N.J. has announced its
financial results for the quarter and year ended December 31, 2002.
Medarex's pro forma net loss for the year ended December 31, . . .
ZILA REPORTS 36% REVENUE GROWTH FOR FISCAL 2ND QTR.
Zila, Inc. (NasdaqNM: ZILA), Phoenix, Ariz., has announced results
for its fiscal second quarter ended January 31, 2003. Highlights of
those results, compared with the same period a year ago, are . . .
INNOVATIVE MEDICAL SERVICES REPORTS 2ND QTR FY2003 NET
LOSS.
Innovative Medical Services (Nasdaq:PURE), San Diego, a biosciences
company that develops and markets technology-based products involving
water purification/treatment, pest control and . . .
ADV. MED OPTICS REPORTS NET INCOME OF $8.8 MILLION FOR 4TH
QTR.(Advanced Medical Optics, Inc. )
Advanced Medical Optics, Inc. (NYSE:AVO), Santa Ana, Calif., a
global leader in ophthalmic surgical devices and eye care products, has
announced its financial results for the quarter and the year . . .
TUTOGEN REPORTS 1ST QTR FY 2003 REVENUES INCREASED 31%.(Tutogen
Medical Inc.)
Tutogen Medical, Inc., (AMEX: TTG), West Paterson, N.J. has
reported first quarter FY 2003 financial results.
For the three months ended December 31, 2002 revenues increased
over 31% to $6.6 . . .
DYAX REPORTS NET LOSS FOR 4TH QTR AND YEAR-END 2002.(Dyax
Corp.)
Dyax Corp. (Nasdaq: DYAX), Cambridge, Mass.,has announced financial
results for the fourth quarter and year ended December 31, 2002.
For the quarter ended December 31, 2002, the company reported . . .
HYCOR REPORTS INCREASE IN 4TH QTR AND YEAR-END PROFIT.(Hycor
Biomedical Inc.)
Hycor Biomedical Inc. (Nasdaq:HYBD), Garden Grove, Calif., has
reported net income of $1,257,000, or $0.15 per share, for the 12 months
ended Dec. 31, 2002, compared with net income of $43,000, or . . .
|
|